Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

MAPT Antibody


Biorbyt logo
View Antibody details

MAPT Antibody


Biorbyt logo
View Antibody details

MAPT Antibody


Biorbyt logo
View Antibody details

Margetuximab Biosimilar – Anti-ERBB2/ EGFR2/ CD340 mAb – Research Grade


Proteo Genix logo
View Antibody details

Maridebart Biosimilar – Anti-Gastric inhibitory polypeptide receptor mAb – Research Grade


Proteo Genix logo
View Antibody details

Marstacimab Biosimilar – Anti-TFPI mAb – Research Grade


Proteo Genix logo
View Antibody details

MAS1L Antibody


Biorbyt logo
View Antibody details

Masavibart Biosimilar – Anti-SARS-CoV-2 Spike RBD mAb – Research Grade


Proteo Genix logo
View Antibody details

Maslimomab Biosimilar – Anti-T cell receptor mAb – Research Grade


Proteo Genix logo
View Antibody details

Matuzumab Biosimilar – Anti-EGFR mAb – Research Grade


Proteo Genix logo
View Antibody details